Reuters logo
7 months ago
BRIEF-Eyegate receives additional milestone payment from Valeant Pharmaceuticals for EGP-437
January 9, 2017 / 1:43 PM / 7 months ago

BRIEF-Eyegate receives additional milestone payment from Valeant Pharmaceuticals for EGP-437

Jan 9 (Reuters) - Eyegate Pharmaceuticals Inc

* Eyegate receives additional milestone payment from Valeant Pharmaceuticals for EGP-437

* Remain on track to submit NDA for potential FDA approval of EGP-437 in Uveitis by end of year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below